List view / Grid view
21 January 2015 | By Aurora
A once daily injection has been approved for adults with type 2 diabetes and moderate renal impairment (stage 3 chronic kidney disease) in the UK...
21 January 2015 | By Citigate Dewe Rogerson
Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces that its IND for Nefecon® is now open with the US Food & Drug Administration...
21 January 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a number of leadership changes approved by its board of directors and effective at the close of the annual Shareholders’ Meeting on May 5...
21 January 2015 | By GlobalData
With the US Food and Drug Administration (FDA) approving an all-time record number of orphan drugs during 2014, the pricing of these treatments is set to come under increased scrutiny, says an analyst with research and consulting firm GlobalData...
21 January 2015 | By Distributed by APO (African Press Organization) on behalf of Rotary International
Nigeria marks progress, having gone six months without a case of polio...
20 January 2015 | By Edelman
We believe NPS is a solid acquisition and are confident management can extract significant Revenue and operating synergies, with focus on the 24 Jan FDA action on Natpara...
20 January 2015 | By B3C newswire
TAVIguide™ supports transcatheter aortic valve implantation (TAVI)...
19 January 2015 | By Celgene
An oral therapy for moderate-to-severe chronic plaque psoriasis and active psoriatic arthritis, with no drug-specific pre-screening or laboratory monitoring requirements...
19 January 2015 | By The UK Clinical Pharmacy Association and Pharmacy Research UK
The UK Clinical Pharmacy Association (UKCPA) and Pharmacy Research UK are continuing their partnership in 2015 to offer a research fund of up to £50,000 to support pharmacy practitioners to take forward their research within clinical pharmacy...
19 January 2015 | By Novo Nordisk
Novo Nordisk announced Switzerland as the first country to launch Xultophy® (IDegLira) for people with type 2 diabetes...
19 January 2015 | By Alliance Pharma plc
Alliance Pharma plc, the speciality pharmaceutical company, announces its pre-close trading update ahead of its preliminary results for the year ended 31 December 2014...
19 January 2015 | By Roche
Today Roche opened its new Learning Center in Kaiseraugst. Besides offering a superlative infrastructure for trainees, the Learning Center contains a state-of-the-art school laboratory, which in this form is unparalleled in Switzerland...
19 January 2015 | By Boehringer Ingelheim
Boehringer Ingelheim today announced that the European Commission (EC) has approved nintedanib* for the treatment of idiopathic pulmonary fibrosis (IPF), following an expedited review and positive CHMP opinion on 20 November 2014. Nintedanib* will be marketed in the EU under the brand name OFEV®...
19 January 2015 | By Public Health England press office
10-point action plan aims to eradicate TB across England...
19 January 2015 | By Public Health England Press Office
All appropriate public health actions taken to support individuals and protect public health...
